39
Participants
Start Date
August 31, 2001
Primary Completion Date
November 30, 2006
aerosol sargramostim
sargramostim
cisplatin
doxorubicin hydrochloride
ifosfamide
mitomycin C
flow cytometry
immunological diagnostic method
laboratory biomarker analysis
adjuvant therapy
multimodality therapy
neoadjuvant therapy
therapeutic conventional surgery
intraoperative radiation therapy
selective external radiation therapy
Lead Sponsor
National Cancer Institute (NCI)
NIH
Mayo Clinic
OTHER